S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.10
+360.20
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
18.50
+1.82
+10.91%
G · GENPACT LIMITED
NEW YORK STOCK EXCHANGE, INC. - Real Time Price • USD
Genpact Ltd (G)
NEW YORK STOCK EXCHANGE, INC.
Professional Services
$39.33
+0.61
(+1.58%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$39.33
$38.45
$39.49
52-WEEK RANGE
$39.33
$26.85
$48.64
What's happening
- G is up 1.58% today, trading at $39.33. — Live quote
- Volume today (192,791) is well below its 3-month average of 2,252,540. (Finnhub fundamentals)
- Reports earnings on 2026-11-05 (after market close), 14 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $1.00 actual vs. $0.98 estimated (+1.6%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 5
Buy 5
Hold 9
Sell 1
Strong sell 0
Aggregate ratings for 2026-10-01 (20 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
G
-15.93%
vs S&P 500
-29.30%
1-YEAR RETURN
G
-2.38%
vs S&P 500
-17.55%
6-MONTH RETURN
G
+6.50%
3-MONTH RETURN
G
+31.06%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$1.00
Est. $0.98
BEAT +1.6%
2026-04-26 (Q1 2026)
$0.98
Est. $0.94
BEAT +4.2%
2026-01-26 (Q4 2025)
$0.97
Est. $0.95
BEAT +1.8%
2025-10-26 (Q3 2025)
$0.97
Est. $0.92
BEAT +5.9%
Valuation Measures & Ratios
Enterprise Value4$7.18B
Forward P/E57.71
PEG Ratio60.98
Price / Sales (TTM1)1.24
Price / Book71.79
EV4 / Revenue1.37
EV4 / EBITDA8.96
Profit Margin11.10%
Operating Margin14.83%
Return on Equity (ROE8)22.91%
Return on Assets (ROA9)10.48%
Avg Volume (3M)2,252,540
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $4.64B | $6.34B | $7.22B | $7.61B | $8.79B |
| P/E | 8.10 | 11.37 | 13.31 | 14.68 | 17.49 |
| Price/Sales | 0.89 | 1.25 | 1.45 | 1.57 | 1.86 |
| Price/Book | 1.78 | 2.56 | 2.84 | 2.94 | 3.58 |
| EV/Revenue | 1.02 | 1.44 | 1.54 | 1.68 | 2.00 |
| ROE | 21.97% | 22.52% | 21.31% | 20.04% | 20.49% |
| ROA | 10.57% | 9.92% | 10.11% | 9.77% | 10.27% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short11,030,143
Change from Prior Settlement+1.27%
% of Float—
Days to Cover (Short Ratio)5.97
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 7.1% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is 11.1%. Finnhub fundamentals ↗
Potential concerns
- Trailing 52-week price return is -2.4%. Finnhub market metrics ↗
- Latest SEC filing is Form 4, filed 2026-09-16; review it for current changes and risks. SEC EDGAR ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on G
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.34B | $1.30B | $1.29B | $1.25B | $1.21B | $1.21B | $1.18B | $1.13B |
| Gross profit | $490.3M | $471.7M | $469.7M | $450.1M | $429.0M | $431.4M | $416.4M | $396.5M |
| Operating income | $192.9M | $198.6M | $191.6M | $179.4M | $183.7M | $181.7M | $170.3M | $160.0M |
| Net income | $145.7M | $148.0M | $145.8M | $132.7M | $130.9M | $132.8M | $122.0M | $116.9M |
| EPS (diluted) | $0.86 | $0.86 | $0.83 | $0.75 | $0.73 | $0.74 | $0.67 | $0.64 |
| EPS (basic) | $0.86 | $0.87 | $0.84 | $0.76 | $0.75 | $0.75 | $0.68 | $0.65 |
| Operating margin | $14 | $15 | $15 | $14 | $15 | $15 | $14 | $14 |
| Net margin | $11 | $11 | $11 | $11 | $11 | $11 | $10 | $10 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $5.41B | $5.62B | $5.84B | $5.36B | $5.31B | $4.89B | $4.99B | $5.33B |
| Total liabilities | $2.81B | $3.14B | $3.29B | $2.82B | $2.72B | $2.44B | $2.60B | $2.93B |
| Stockholders' equity | $2.60B | $2.48B | $2.55B | $2.54B | $2.59B | $2.45B | $2.39B | $2.39B |
| Total current assets | $2.17B | $2.41B | $2.66B | $2.21B | $2.14B | $1.94B | $2.08B | $2.40B |
| Total current liabilities | $1.09B | $1.43B | $1.60B | $1.46B | $1.39B | $791.7M | $963.7M | $1.29B |
| Cash & equivalents | $517.4M | $578.1M | $853.8M | $740.8M | $663.3M | $561.6M | $648.2M | $1.02B |
| Marketable securities (current) | $0 | $350.0M | $350.0M | $0 | $0 | $0 | $23.4M | — |
| Accounts receivable | $1.40B | $1.26B | $1.24B | $1.28B | $1.27B | $1.19B | $1.20B | $1.21B |
| Other current assets | $59.8M | $36.3M | $43.7M | $18.5M | $15.1M | $16.0M | $33.0M | $13.7M |
| Property, plant & equipment | $184.4M | $180.7M | $190.4M | $180.7M | $219.4M | $210.7M | $207.9M | $207.6M |
| Goodwill | $1.77B | $1.77B | $1.78B | $1.78B | $1.79B | $1.67B | $1.67B | $1.68B |
| Intangible assets | $73.3M | $69.7M | $67.0M | $71.4M | $77.4M | $22.6M | $26.9M | $33.3M |
| Other non-current assets | $573.5M | $544.5M | $510.4M | $477.4M | $435.4M | $402.6M | $349.8M | $326.0M |
| Accounts payable | $16.1M | $26.2M | $27.5M | $34.8M | $43.9M | $37.3M | $36.5M | $18.5M |
| Accrued liabilities | $299.2M | $239.6M | $221.3M | $207.0M | $193.7M | $178.7M | $199.6M | $194.7M |
| Deferred revenue (current) | $152.6M | $189.2M | $203.1M | $125.3M | $93.9M | $95.2M | $101.9M | $105.7M |
| Short-term debt | $26.2M | $376.2M | $376.0M | $375.9M | $375.7M | $26.2M | $26.2M | $426.1M |
| Other current liabilities | $931.0M | $926.4M | $1.10B | $945.4M | $777.7M | $635.8M | $813.0M | $747.5M |
| Long-term debt | $1.15B | $1.16B | $1.17B | $827.0M | $833.4M | $1.19B | $1.20B | $1.20B |
| Other non-current liabilities | $401.4M | $384.5M | $353.4M | $360.0M | $315.3M | $290.1M | $269.0M | $261.2M |
| Common stock & paid-in capital | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | $1.8M |
| Retained earnings | $1.50B | $1.44B | $1.39B | $1.37B | $1.35B | $1.27B | $1.24B | $1.21B |
| Accumulated other comprehensive income (loss) | -$947.6M | -$984.5M | -$861.4M | -$822.5M | -$727.5M | -$764.9M | -$794.1M | -$736.5M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $72.4M | -$23.5M | $286.7M | $308.4M | $177.4M | $40.4M | $203.2M | $228.5M |
| Investing cash flow | $331.2M | -$31.4M | -$371.9M | -$19.2M | -$105.2M | $779.0K | -$41.3M | -$20.3M |
| Financing cash flow | -$440.9M | -$204.3M | $208.8M | -$209.0M | $18.9M | -$125.5M | -$517.4M | -$109.7M |
| Free cash flow | $58.5M | -$47.5M | $269.0M | $292.0M | $155.1M | $18.5M | $183.5M | $208.7M |
| Capital expenditures | $13.9M | $23.9M | $17.7M | $16.3M | $22.2M | $22.0M | $19.7M | $19.8M |
| Share-based compensation | $26.4M | $22.3M | $69.6M | $22.2M | $21.8M | $20.0M | $57.2M | $19.7M |
| Deferred income taxes | -$9.2M | $8.6M | $8.2M | $2.4M | $1.2M | $8.1M | $22.1M | -$1.4M |
| Change in accounts receivable | $146.3M | $29.0M | -$36.1M | $21.6M | $65.7M | -$7.0M | $765.0K | $41.5M |
| Change in accounts payable | -$10.2M | -$1.9M | -$6.2M | -$9.8M | $7.7M | $1.8M | $16.8M | -$9.0M |
| Dividends paid | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | $252.7M | — |
| Debt issued | — | — | $350.0M | $0 | $0 | — | $0 | $0 |
| Debt repaid | $356.6M | $6.6M | $6.6M | $6.6M | $6.6M | $6.6M | $406.6M | $6.6M |
| Tax withholding on stock comp | $3.7M | $18.4M | $1.6M | $955.0K | $132.0K | $30.7M | $971.0K | $165.0K |
| Other financing activities | — | — | — | — | — | — | — | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $5.08B | $4.77B | $4.48B | $4.37B | $4.02B |
| Gross profit | $1.83B | $1.69B | $1.57B | $1.54B | $1.43B |
| Operating income | $750.2M | $702.1M | $630.9M | $502.2M | $509.0M |
| Net income | $552.5M | $513.7M | $631.3M | $353.4M | $369.4M |
| EPS (diluted) | $3.13 | $2.85 | $3.41 | $1.88 | $1.91 |
| EPS (basic) | $3.18 | $2.88 | $3.46 | $1.92 | $1.97 |
| Operating margin | $15 | $15 | $14 | $11 | $13 |
| Net margin | $11 | $11 | $14 | $8 | $9 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $5.84B | $4.99B | $4.81B | $4.59B | $4.98B |
| Total liabilities | $3.29B | $2.60B | $2.56B | $2.76B | $3.08B |
| Stockholders' equity | $2.55B | $2.39B | $2.25B | $1.83B | $1.90B |
| Total current assets | $2.66B | $2.08B | $1.89B | $1.78B | $1.92B |
| Total current liabilities | $1.60B | $963.7M | $1.32B | $1.10B | $1.31B |
| Cash & equivalents | $853.8M | $648.2M | $583.7M | $646.8M | $899.5M |
| Marketable securities (current) | $350.0M | $23.4M | $0 | — | — |
| Accounts receivable | $1.24B | $1.20B | $1.12B | $994.8M | $887.7M |
| Other current assets | $43.7M | $33.0M | $17.5M | $18.7M | $30.7M |
| Property, plant & equipment | $190.4M | $207.9M | $189.8M | $180.8M | $215.1M |
| Goodwill | $1.78B | $1.67B | $1.68B | $1.68B | $1.73B |
| Intangible assets | $67.0M | $26.9M | $53.0M | $89.7M | $169.6M |
| Other non-current assets | $510.4M | $349.8M | $300.0M | $304.1M | $322.2M |
| Accounts payable | $27.5M | $36.5M | $27.7M | $35.8M | $25.0M |
| Accrued liabilities | $221.3M | $199.6M | $165.4M | $126.7M | $162.1M |
| Deferred revenue (current) | $203.1M | $101.9M | $112.4M | $160.6M | $160.6M |
| Short-term debt | $376.0M | $26.2M | $432.2M | $26.1M | $383.4M |
| Other current liabilities | $1.10B | $813.0M | $759.2M | $791.0M | $791.4M |
| Long-term debt | $1.17B | $1.20B | $824.7M | $1.25B | $1.27B |
| Other non-current liabilities | $353.4M | $269.0M | $234.9M | $215.6M | $245.2M |
| Common stock & paid-in capital | $1.7M | $1.7M | $1.8M | $1.8M | $1.8M |
| Retained earnings | $1.39B | $1.24B | $1.09B | $780.0M | $732.5M |
| Accumulated other comprehensive income (loss) | -$861.4M | -$794.1M | -$722.5M | -$733.1M | -$554.4M |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | $812.9M | $615.4M | $490.8M | $443.7M | $694.3M |
| Investing cash flow | -$495.5M | -$106.0M | -$78.9M | -$36.6M | -$122.7M |
| Financing cash flow | -$106.8M | -$424.8M | -$483.0M | -$571.4M | -$332.9M |
| Free cash flow | $734.7M | $532.7M | $435.4M | $393.1M | $640.9M |
| Capital expenditures | $78.2M | $82.8M | $55.4M | $50.6M | $53.3M |
| Share-based compensation | $89.6M | $66.4M | $88.6M | $77.4M | $82.0M |
| Deferred income taxes | $19.9M | $36.6M | -$157.9M | -$29.2M | -$9.3M |
| Change in accounts receivable | $44.2M | $96.6M | $130.8M | $112.3M | $11.8M |
| Change in accounts payable | -$6.4M | $8.7M | -$8.2M | $14.2M | $11.7M |
| Dividends paid | — | — | — | — | — |
| Share repurchases | — | $252.7M | $225.5M | $214.1M | $298.2M |
| Debt issued | $350.0M | $400.0M | $0 | $239.1M | $350.0M |
| Debt repaid | $26.5M | $433.1M | $19.9M | $620.1M | $34.0M |
| Tax withholding on stock comp | $33.4M | $22.3M | $21.5M | $44.9M | $35.7M |
| Other financing activities | — | — | $0 | $0 | -$6.0K |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding G as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-03-03 to 2026-09-14
Recent transactions
- Insiders have net sold 66,158 shares over the last 182 days, across 0 purchases and 7 sales.
- Most recent: Kalra Balkrishan (President and CEO) — Open market sale of 10,000 shares on 2026-09-14.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)66,158 sh(7 txns)
Net Shares-66,158
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Kalra Balkrishan | President and CEO | Open market sale | 2026-09-14 | 10,000 |
| Pandit Sumita | Chief Financial Officer | Grant / award | 2026-09-09 | 76,713 |
| Nanduru Anil | Senior Vice President | Open market sale | 2026-08-19 | 6,191 |
| Dewan Sameer | Senior Vice President | Open market sale | 2026-08-14 | 1,654 |
| Weiner Michael Hal | Chief Financial Officer | Open market sale | 2026-08-13 | 5,900 |
| Hinshaw John M | Director | Grant / award | 2026-04-23 | 6,521 |
| Morken CeCelia | Director | Grant / award | 2026-04-23 | 6,521 |
| Lindstrom Carol | Director | Grant / award | 2026-04-23 | 6,521 |
| Gangestad Nicholas C | Director | Grant / award | 2026-04-23 | 6,521 |
| Subaiya Thimaya K. | Director | Grant / award | 2026-04-23 | 6,521 |
| Verdi Mark A | Director | Grant / award | 2026-04-23 | 6,521 |
| STEVENS BRIAN MARK | Director | Grant / award | 2026-04-23 | 6,521 |
| Conigliaro Laura | Director | Grant / award | 2026-04-23 | 6,521 |
| Madden James C. | Director | Grant / award | 2026-04-23 | 9,999 |
| Vashisht Riju | Senior Vice President | Tax withholding | 2026-03-10 | 7,080 |
| Mehta Piyush | Senior Vice President and CHRO | Tax withholding | 2026-03-10 | 5,702 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-14 | Kalra Balkrishan | President and CEO | Open market sale | 10,000 | $36.79 |
| 2026-09-09 | Pandit Sumita | Chief Financial Officer | Grant / award | 76,713 | $0.00 |
| 2026-08-19 | Nanduru Anil | Senior Vice President | Open market sale | 6,191 | $37.03 |
| 2026-08-14 | Dewan Sameer | Senior Vice President | Open market sale | 1,654 | $34.10 |
| 2026-08-14 | Dewan Sameer | Senior Vice President | Open market sale | 13,318 | $34.10 |
| 2026-08-13 | Weiner Michael Hal | Chief Financial Officer | Open market sale | 5,900 | $34.04 |
| 2026-08-12 | Nanduru Anil | Senior Vice President | Open market sale | 11,852 | $33.92 |
| 2026-08-11 | Nanduru Anil | Senior Vice President | Open market sale | 17,243 | $33.96 |
| 2026-04-23 | Hinshaw John M | Director | Grant / award | 6,521 | $0.00 |
| 2026-04-23 | Morken CeCelia | Director | Grant / award | 6,521 | $0.00 |
| 2026-04-23 | Lindstrom Carol | Director | Grant / award | 6,521 | $0.00 |
| 2026-04-23 | Gangestad Nicholas C | Director | Grant / award | 6,521 | $0.00 |
| 2026-04-23 | Subaiya Thimaya K. | Director | Grant / award | 6,521 | $0.00 |
| 2026-04-23 | Verdi Mark A | Director | Grant / award | 6,521 | $0.00 |
| 2026-04-23 | STEVENS BRIAN MARK | Director | Grant / award | 6,521 | $0.00 |
| 2026-04-23 | Conigliaro Laura | Director | Grant / award | 6,521 | $0.00 |
| 2026-04-23 | Madden James C. | Director | Grant / award | 9,999 | $0.00 |
| 2026-03-10 | Weiner Michael Hal | Chief Financial Officer | Tax withholding | 7,019 | $38.92 |
| 2026-03-10 | Vashisht Riju | Senior Vice President | Tax withholding | 7,080 | $38.92 |
| 2026-03-10 | Nanduru Anil | Senior Vice President | Tax withholding | 7,663 | $38.92 |
| 2026-03-10 | Mehta Piyush | Senior Vice President and CHRO | Tax withholding | 5,702 | $38.92 |
| 2026-03-10 | Dewan Sameer | Senior Vice President | Tax withholding | 3,542 | $38.92 |
| 2026-03-10 | Kalra Balkrishan | President and CEO | Tax withholding | 13,893 | $38.92 |
| 2026-03-04 | Kalra Balkrishan | President and CEO | Option exercise | 2,800 | $27.65 |
| 2026-03-04 | Kalra Balkrishan | President and CEO | Open market sale | 2,800 | $40.77 |
| 2026-03-03 | Kalra Balkrishan | President and CEO | Grant / award | 27,160 | $0.00 |
| 2026-03-03 | Dewan Sameer | Senior Vice President | Grant / award | 6,928 | $0.00 |
| 2026-03-03 | Mehta Piyush | Senior Vice President and CHRO | Grant / award | 14,618 | $0.00 |
| 2026-03-03 | Nanduru Anil | Senior Vice President | Grant / award | 13,856 | $0.00 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 07:30 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-09-16 | 4 | 2026-09-14 | View on SEC.gov → |
| 2026-09-11 | 4 | 2026-09-09 | View on SEC.gov → |
| 2026-09-08 | 8-K | 2026-09-03 | View on SEC.gov → |
| 2026-08-20 | 4 | 2026-08-19 | View on SEC.gov → |
| 2026-08-18 | 4 | 2026-08-14 | View on SEC.gov → |
| 2026-08-14 | 4 | 2026-08-13 | View on SEC.gov → |
| 2026-08-13 | 4 | 2026-08-11 | View on SEC.gov → |
| 2026-08-07 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-06 | 8-K | 2026-08-06 | View on SEC.gov → |
| 2026-05-08 | 10-Q | 2026-03-31 | View on SEC.gov → |
| 2026-05-07 | 8-K | 2026-05-07 | View on SEC.gov → |
| 2026-04-29 | 8-K | 2026-04-23 | View on SEC.gov → |
Recent news
Headlines about G (GENPACT LIMITED). Links open the publisher — we don’t host full articles.
-
Gen.G Canyon Shares The ONE Thing The Team Learned In 2026
Hotspawn · 2026-10-22 -
DXC Technology Co (DXC) Stock Up 5.3% and Still Undervalued -- GF Score: 62/100
GuruFocus · 2026-10-22 -
G.NA shares bold Black Swan inspired visuals amid comeback interest
미디어파인 · 2026-10-21 -
Genpact Limited (G) Stock Forecasts
Yahoo Finance · 2026-10-21 -
G-III Apparel Group, LTD. (GIII) Stock Forecasts
Yahoo Finance · 2026-10-21 -
(AI.DB.G) Comprehensive Trading Strategy Report (AI.DB.G:CA)
Stock Traders Daily · 2026-10-21 -
Learn to Evaluate (PBH.DB.G) using the Charts
Stock Traders Daily · 2026-10-21 -
Innodata's 12-Quarter Growth Streak: How Much Runway Is Left?
Yahoo · 2026-10-21
No headlines in this category right now — try “All”.